healthdoctor - intellinewz.com - Page 13 of 63

About healthdoctor

Dr. Mohammed Abdul Azeem Siddiqui, MBBS, M.Tech (Biomedical Engineering – VIT, Vellore) Registered Medical Practitioner – Reg. No. 39739 Physician • Clinical Engineer • Preventive Diagnostics Specialist Dr. Mohammed Abdul Azeem Siddiqui is a physician–engineer with over 30 years of dedicated clinical and biomedical engineering experience, committed to transforming modern healthcare from late-stage disease treatment to early detection, preventive intelligence, and affordable medical care. He holds an MBBS degree in Medicine and an M.Tech in Biomedical Engineering from VIT University, Vellore, equipping him with rare dual expertise in clinical medicine, laboratory diagnostics, and medical device engineering. This allows him to translate complex laboratory data into precise, actionable preventive strategies. Clinical Mission Dr. Siddiqui’s professional mission centers on three core pillars: Early Disease Detection Identifying hidden biomarker abnormalities that signal chronic disease years before symptoms appear — reducing complications, hospitalizations, and long-term disability. Preventive Healthcare Guiding individuals and families toward longer, healthier lives through structured screenings, lifestyle intervention frameworks, and predictive diagnostic interpretation. Affordable Evidence-Based Treatment Delivering cost-effective, scientifically validated care accessible to people from all socioeconomic backgrounds. Clinical & Technical Expertise Across three decades of continuous practice, Dr. Siddiqui has worked extensively with: Advanced laboratory analyzers and automation platforms • Cardiac, metabolic, renal, hepatic, endocrine, and inflammatory biomarker systems • Preventive screening and early organ damage detection frameworks • Clinical escalation pathways and diagnostic decision-support models • Medical device validation, calibration, compliance, and patient safety standards He is recognized for identifying subclinical biomarker shifts that predict cardiovascular disease, diabetes, fatty liver, kidney disease, autoimmune inflammation, neurodegeneration, and accelerated biological aging long before conventional diagnosis. Role at IntelliNewz At IntelliNewz, Dr. Siddiqui serves as Founder, Chief Medical Editor, and Lead Clinical Validator. Every article published is: Evidence-based • Clinically verified • Technology-grounded • Free from commercial bias • Designed for real-world patient and physician decision-making Through his writing, Dr. Siddiqui shares practical health intelligence, early warning signs, and preventive strategies that readers can trust — grounded in decades of frontline medical practice. Contact: powerofprevention@outlook.com 📌 Disclaimer: The content on IntelliNewz is intended for educational purposes only and does not replace personalized medical consultation. For individual health concerns, please consult your physician.

healthline

BIOMEDICAL RESEARCH. LATEST

Keytruda Immunotherapy 2026: How It Works, What Cancers It Treats & 7 Signs It’s Working

1. Tumor Shrinkage on Imaging Scans (The Gold Standard) The most definitive sign is a reduction in tumor size or complete disappearance of tumors, as seen on CT, PET, or MRI…

healthdoctor April 14, 2026

rizmeeshireen

BIOMEDICAL RESEARCH. LATEST

Urgent: Liver Disease Explained – When Is a Transplant the Only Life-Saving Option?

The liver is the body's silent workhorse. Weighing about three pounds, this reddish-brown organ sits in the upper right abdomen, performing over 500 vital functions—filtering toxins, producing bile for digestion,…

healthdoctor April 13, 2026

rizmeeshireen

Genetic Predisposition: The Major Non-Modifiable Risk Factor Driving Modern Cancer Prevention Research (2026)

Cancer risk arises from a complex interplay between genes, environment, and lifestyle. Among these, genetic predisposition stands out as a major non-modifiable risk factor—you cannot change the DNA you inherit,…

healthdoctor April 13, 2026

rizmeeshireen

Combining Biomarkers with Clinical Risk Factors to Improve Thrombosis Prediction in Gynaecological Cancer

Introduction Cancer-associated thrombosis (CAT) remains a leading cause of non-cancer mortality in women with gynaecological malignancies. Traditional clinical risk scores provide a useful baseline, but their predictive accuracy is often…

healthdoctor April 13, 2026